Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

Arthritis Care and Research

Volumn 62, Issue 1, 2010, Pages 63-72

  Ravelli, Angelo ^a   Trail, Lucia ^a   Ferrari, Cristina ^a   Ruperto, Nicolino ^a   Pistorio, Angela ^a   Pilkington, Clarissa ^b   Maillard, Susan ^b   Oliveira, Sheila K ^c   Sztajnbok, Flavio ^d   Cuttica, Ruben ^e   Beltramelli, Matilde ^f   Corona, Fabrizia ^f   Katsicas, Maria Martha ^g   Russo, Ricardo ^g   Ferriani, Virginia ^h   Burgos Vargas, Ruben ⁱ   Magni Manzoni, Silvia ^f   Solis Vallejo, Eunice ^j   Bandeira, Marcia ^k   Zulian, Francesco ^l   Baca, Vicente ^m   Cortis, Elisabetta ⁿ   Falcini, Fernanda ^o   Alessio, Maria ^p   Alpigiani, Maria Giannina ^a   Gerloni, Valeria ^q   Saad Magalhaes, Claudia ^r   Podda, Rosanna ^s   Silva, Clovis A ^h   Lepore, Loredana ^t   Felici, Enrico ^a   Rossi, Federica ^a   Sala, Elena ^a   Martini, Alberto ^a   more..

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ HOSPITAL GENERAL DE MÉXICO   (Mexico)

^j Centro Medical National la Raza   (Mexico)

^k HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

^l Clinica Pediatrica I   (Italy)

^m INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

ⁿ BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^o Ospedale Villa Monna Tessa   (Italy)

^p UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^q ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^r SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^s II Clinica Pediatrica   (Italy)

^t Istituto di Ricovero e Cura a Carattere Scientifico Burlo Garofalo   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CALCINOSIS; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; JUVENILE; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE EXERCISE; MUSCLE INJURY; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PROGNOSIS; QUALITY OF LIFE; SKIN INJURY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; INFANT; INTERNATIONALITY; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 74549143737     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20015     Document Type: Article

References (27)

1. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201-12.
2. Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al, for the NIAMS Juvenile DM Registry Physician Referral Group. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003;49:300-5.
3. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995;34:732-6.
4. Huber A, Feldman BM. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Curr Rheumatol Rep 2005;7:441-6.
5. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, et al. Medium-and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43:541-9.
6. Oddis CV. Idiopathic inflammatory myopathies: a treatment update. Curr Rheumatol Rep 2003;5:431-6.
7. Stringer E, Feldman BM. Advances in the treatment of juvenile dermatomyositis. Curr Opin Rheumatol 2006;18:503-6.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
10. Spencer CH, Hanson V, Singsen BH, Bernstein BH, Kornreich HK, King KK. Course of treated juvenile dermatomyositis. J Pediatr 1984;105:399-408.
11. Bowyer SL, Blane CE, Sullivan DB, Cassidy JT. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983;103: 882-8.
12. Stringer E, Singh-Grewal D, Feldman BM. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 2008;58:3585-92.
13. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004;43:49-54.
14. Kendall FP, McCreary EK, Provance PG. Muscles: testing and function. 4th ed. Baltimore: Williams & Wilkins; 1993.
15. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Gianni EH, et al, and the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999;42: 2213-9.
16. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49:7-15.
17. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
18. Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology. Clin Exp Rheumatol 2001;19 Suppl 23:S1-9.
19. Landgraf JM, Abetz L, Ware JE. The CHQ user's manual. 1st ed. Boston: The Health Institute; 1996.
20. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595-603.
21. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9.
22. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006;148:247-53.
23. McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al, and the Juvenile Dermatomyositis Research Group. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland): clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford) 2006;45:1255-60.
24. Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM, et al, for the Pediatric Rheumatology International Trials Organization. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. Arthritis Rheum 2007;57:35-43.
25. Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, et al. Health-related quality of life in juvenileonset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004;51:458-64.
26. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002;47:505-11.
27. Tabarki B, Ponsot G, Prieur AM, Tardieu M. Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. Eur J Paediatr Neurol 1998;2: 205-11.